Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD30/TNFRSF8 Antibody (Ki-1/779) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
$634.00
Specifications
Antigen | CD30/TNFRSF8 |
---|---|
Clone | Ki-1/779 |
Concentration | 1.0 mg/mL |
Dilution | Flow Cytometry : 0.5 - 1 ug/million cells in 0.1 ml, Immunohistochemistry-Paraffin : 0.5 - 1.0 ug/ml, Immunofluorescence : 1 - 2 ug/ml, CyTOF-ready |
Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence, CyTOF |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP247906A
|
Novus Biologicals
NBP2479060.1MG |
0.1 mg |
Each for $634.00
|
|
|||||
NBP247906B
|
Novus Biologicals
NBP2479060.2MG |
0.2 mg | Item Discontinued This item has been discontinued by the supplier. Please Sign In to view product availability in your area. | N/A | |||||
Description
CD30/TNFRSF8 Monoclonal specifically detects CD30/TNFRSF8 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunofluorescence, CyTOF-ready.Specifications
CD30/TNFRSF8 | |
1.0 mg/mL | |
Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence, CyTOF | |
Unconjugated | |
Mouse | |
Apoptosis, B Cell Development and Differentiation Markers, Cell Cycle and Replication, Embryonic Stem Cell Markers, Immunology, Stem Cell Markers | |
PBS with No Preservative | |
943 | |
Recombinant human TNFRSF8 protein | |
Primary | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Ki-1/779 | |
Flow Cytometry : 0.5 - 1 ug/million cells in 0.1 ml, Immunohistochemistry-Paraffin : 0.5 - 1.0 ug/ml, Immunofluorescence : 1 - 2 ug/ml, CyTOF-ready | |
Monoclonal | |
Purified | |
RUO | |
Human | |
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8 | |
TNFRSF8 | |
IgG1 κ | |
Protein A or G purified | |
Recognizes a single chain glycoprotein of 105/120kDa, identified as CD30/Ki-1. CD30 is synthesized as a 90kDa precursor, which is processed in the Golgi complex into a membrane-bound phosphorylated mature 105/120kDa glycoprotein. In Hodgkins disease, CD30/Ki-1 antigen is expressed by mononuclear-Hodgkin and multinucleated Reed-Sternberg cells. It is also expressed by the tumor cells of a majority of anaplastic large cell lymphomas as well as by a varying proportion of activated T and B cells. This MAb distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas. About one third of the Ki-1 positive lymphomas lack the leukocyte common antigen (CD45). |
Spot an opportunity for improvement?
Product Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title